CEL-SCI
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Employees
- 44
- Market Cap
- $68.8M
- Introduction
CEL-SCI Corp. is a biotechnology company, which engages in the research, development and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of...
Study of Leukocyte Interleukin, Injection for Treatment of Perianal Warts
- First Posted Date
- 2017-02-01
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- CEL-SCI Corporation
- Target Recruit Count
- 8
- Registration Number
- NCT03038828
- Locations
- ๐บ๐ธ
Naval Medical Center San Diego, San Diego, California, United States
๐บ๐ธUniversity of California San Francisco, San Francisco, California, United States
Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity
- First Posted Date
- 2010-12-23
- Last Posted Date
- 2022-08-19
- Lead Sponsor
- CEL-SCI Corporation
- Target Recruit Count
- 928
- Registration Number
- NCT01265849
- Locations
- ๐จ๐ณ
Linkou Branch Chang Gung Memorial Hospital, Guishan, Taoyuan, Taiwan
๐ฎ๐ณMeenakshi Mission Hospital and Research Centre, Madurai, Tamil Nadu, India
๐จ๐ฆSt. Josephs Healthcare Department of Surgery, Hamilton, Ontario, Canada
ยฉ Copyright 2024. All Rights Reserved by MedPath